|
|||||
|
|
Effect of Rimonabant on Glycemic Control in Insulin-Treated Type 2 Diabetes: The ARPEGGIO Trial |
|
| Authors: | Priscilla A. Hollander Aslam Amod Le��n E. Litwak Umesh Chaudhari for the ARPEGGIO Study Group |
| Affiliation: | 1Baylor University Medical Center, Dallas, Texas; ;2Centre for Diabetes, Endocrinology and Metabolic Diseases, Chatsmed Garden Hospital, Durban, South Africa; ;3Hospital Italiano de Buenos Aires, Ciudad de Buenos Aires, Buenos Aires, Argentina; ;4sanofi-aventis U.S., Bridgewater, New Jersey. |
| Abstract: | |
| Keywords: | |